BARR GENERIC WARFARIN TO BE LAUNCHED IN SUMMER; DUPONT MERCK CONTINUES EFFORTS TO PASS STATE LAWS REQUIRING PHYSICIAN APPROVAL FOR NTI SUBSTITUTION

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".